Financhill
Back

Spero Therapeutics Stock Predictions

Spero Therapeutics Stock Forecast

  • Is Spero Therapeutics Stock Undervalued?
    The current Spero Therapeutics [SPRO] share price is $2.91. The Score for SPRO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SPRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Spero Therapeutics Stock Go Up Next Year?

Data Unavailable

Spero Therapeutics Stock Rating

Data Unavailable

Spero Therapeutics Stock Price History

Is SPRO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sperotherapeutics.com

52-Week Data

52-Week High:
3.09
52-Week Low:
0.51

Prediction Charts

Market Cap:
162.7M
Price in USD:
2.91
Volume:
390.1K
Beta:
1.59

Technical Analysis

SMA50:
1.76
SMA100:
1.26
SMA200:
1.20
52-Wk Change:
119.62%

Stock Predictions

  • Is Spero Therapeutics stock public?
    Yes, Spero Therapeutics is a publicly traded company.
  • What is the Spero Therapeutics stock quote today?
    The Spero Therapeutics stock price is 2.91 USD today.
  • How to buy Spero Therapeutics stock online?
    You can buy Spero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-16 2.84 2.85 2.95 2.83
Jun-17 2.85 2.90 2.95 2.81
Jun-18 2.95 2.94 2.98 2.86
Jun-20 2.93 3.02 3.02 2.87
Jun-23 3.00 2.93 3.00 2.88
Jun-24 2.97 2.88 2.97 2.81
Jun-25 2.90 2.90 2.93 2.79
Jun-26 2.94 2.90 2.94 2.87
Jun-27 2.91 2.94 3.09 2.90
Jun-30 2.99 2.90 3.00 2.90
Jul-1 2.92 2.90 2.95 2.90
Jul-2 2.90 2.90 3.03 2.90
Jul-3 2.90 2.91 2.94 2.90
Jul-7 2.91 2.90 2.94 2.90

Spero Therapeutics Earnings

Data Unavailable

Spero Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $1.14 per share.

* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.